Purity, COAs & Sourcing
Certificates of analysis, third-party testing, batch records and how suppliers are checked.
30 articles in this topic. For research and educational reference only.
- How a 2% impurity can wreck months of peptide research
- How Batch Transparency Saves Your Peptide Vials
- Synthetic Peptides as Drugs: The Purity Documentation Shift
- The amino acid building blocks your purity test might miss
- The GLP-1 purity problem hiding in plain sight online
- What a bacterial enzyme reveals about cyclic peptide purity
- What Amazon's GLP-1 push means for your peptide purity
- What the GLP-1 drug race means for your vial purity checks
- What the numbers on your peptide CoA actually mean
- What the peptide boom means for your vial's purity
- What Your Peptide Vial's Purity Label Actually Guarantees
- Who actually checks your peptide supplier's purity claims?
- Who really controls your peptide purity?
- Why approved peptides set the purity bar for your research
- Why novel NRPS peptides are harder to source than you think
- Why one mass number can't prove your peptide is pure
- Why Pure Peptidoglycan Fragments Matter for Your Bench Assays
- Why Sermorelin-GHRP-6 blends demand stricter purity checks
- Why sourcing your research peptides just got more complicated
- Why the GLP-1 boom raises your counterfeit peptide risk
- Why the GLP-1 rush makes your peptide sourcing riskier
- Why your BPC-157 vial's purity number might be fake
- Why your GLP-1 class peptide CoA might be hiding impurities
- Why your marine tripeptide source needs a closer look
- Why your peptide COA might not mean what you think
- Why your peptide's COA doesn't tell the whole purity story
- Why your peptide's purity claim might be a lie
- Your GLP-1 Purity Might Vary More Than You Think
- Your Peptide Vial's Purity Problem Starts at Sourcing
- Your Peptide's Purity Has a New Benchmark
